Blocknomi
Key Highlights Shares of Definium Therapeutics climbed approximately 52% on June 22, 2026, following positive Phase 3 Emerge trial results for DT120 in treating major depressive disorder The experimental treatment…
Related articles
-
Microsoft President Asks Graduates to Stop Fearing AI and Start Adapting
Decrypt Published 11.06.2026 20:25
-
Miner Capitulation Risk: Why 20% Unprofitable Hashrate Could Pressure Bitcoin’s Next Bounce
Crypto Daily Published 21.06.2026 12:21
-
Solana Real-World Assets Gain Momentum With Significant Spike In Transfer Activity
Bitcoinist Published 11.06.2026 00:00
-
Crypto Becomes Hot-Button Election Issue
U.Today Published 10.06.2026 17:36
-
Crypto News, June 19: Bitcoin at Risk as Strategy STRC Cracks its Peg, Microsoft Warns Windows Crypto Users, Iran Suspends Peace Talks
Cryptonews Published 19.06.2026 10:26
-
Bank of England Softens Stablecoin Rules With £40 Billion Issuer Cap
NewsBTC Published 22.06.2026 09:34
-
XPower Finance and HPX Unite to Bring AI-Powered Finance to X Layer
BlockchainReporter Published 16.06.2026 15:00
-
3 Token Unlocks to Watch in the Final Week of June 2026
BeInCrypto Published 22.06.2026 05:00